Smiths Medical receives FDA clearance for epidural administration safety system


Intravenous products: MarketWatch report “Smiths Medical, a leading global medical device manufacturer, today announced that its Portex(R) CorrectInject(TM) Safety System for administering neuraxial (spinal and epidural) medication received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

The CorrectInject(TM) Safety System is intended to enhance patient safety by helping to reduce the risk of tubing misconnections, while minimizing changes to clinical technique. Tubing misconnections often occur, as epidural, intravenous, enteral and other infusion lines look alike. The connectors of the CorrectInject(TM) Safety System are uniquely tapered and threaded to be intentionally incompatible with standard Luer connectors. The CorrectInject(TM) Safety System’s yellow components visually signify a neuraxial delivery route and are intended to prompt clinicians to check that the medication to be delivered is appropriate for the treatment location.”

Click here for the full press release.

Main page


Comments are closed.